SCHEMBL381398

SCHEMBL381398

CN(CCCN(CCc1ccccc1)C(=O)O)C(=O)c1ccc(CO)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
THPO P40225 1/20 0.40
BLM P54132 1/20 0.40
PMP22 Q01453 1/20 0.40
KMT2A Q03164 1/20 0.40
HIF1A Q16665 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
RCE1 Q9Y256 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15061458 0.84 MEN1 (0.41) CNR1TDP1KDM4EMEN1ALDH1A1
SCHEMBL381397 0.80 HDAC1 (0.41) CNR1TDP1ALDH1A1MAPTKMT2A
SCHEMBL381658 0.80 PAX8 (0.38) CNR1TDP1L3MBTL1NPC1RAB9A
SCHEMBL381070 0.78 GLS (0.40)
SCHEMBL27850558 0.77 P4HTM (0.37) CNR1TDP1KDM4EMEN1ALDH1A1
SCHEMBL381396 0.74 MME (0.37) CNR1CYP3A4FAAH
SCHEMBL15061460 0.74 TSHR (0.37) CNR1TDP1KDM4EMEN1ALDH1A1
SCHEMBL30503685 0.72 KDM4E (0.43) CNR1TDP1KDM4EMEN1ALDH1A1
SCHEMBL29024939 0.72 KDM4E (0.43) CNR1TDP1KDM4EMEN1ALDH1A1
SCHEMBL23120228 0.70 TDP1 (0.54) TDP1MEN1MAPTKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120071467-A1 AMIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-03-22 US disclosed
EP-2409977-A1 AMIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2012-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071467-A1 AMIDE DERIVATIVE CHRM3, CHRM2, TACR2 CNR1 143/4885TDP1 4823/4885KDM4E 1529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.